
    
      This 12 month, multicenter, open-label registry is designed to collect treatment and outcome
      data related to participants treated with Varithena for great saphenous vein (GSV) system
      and/or anterior accessory saphenous vein (AASV) incompetence resulting in VLU. Participant
      are treated per Investigator's Standard of Care (SoC) and in accordance with the Full
      Prescribing Information (FPI) and Instructions for Use (IFU). For participants with healed
      ulcers during the 12 month follow-up period, VLU recurrence information is collected.
    
  